Clinicopathological Analysis of the Expression of CD44v6 in Primary Thyroid Cancer and Recurrent Regional Lymph Nodes

UGA Tatsuya; MAEDA Shigeto; IWATA Tohru; FURUI Junichiro; KANEMATSU Takashi

Art

J-GLOBAL ID：200902252907597645 Reference number：07A0633841

Clinicopathological Analysis of the Expression of CD44v6 in Primary Thyroid Cancer and Recurrent Regional Lymph Nodes

原発性甲状腺癌と再発性局所リンパ節におけるCD44v6の発現の臨床病理学的分析

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=07A0633841&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0633841&from=J-GLOBAL&jstjournalNo=X0952A") }}

Author (5)： , , , ,
Material：
Volume： 52 Issue： 2 Page： 53-57 Publication year： Jun. 2007
JST Material Number： X0952A ISSN： 0001-6055 Document type： Article
Article type：原著論文 Country of issue： Japan (JPN) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0633841&from=J-GLOBAL&jstjournalNo=X0952A") }}

Tumors(=neoplasms)of endocrine system , Diagnosis of tumors(=neoplasms)

Reference (19)：

Weber GF. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 1552: 61-85, 2001
Bohm JP, Niskanen LK, Pirinen RT et al. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma. J Pathol 192: 321-327, 2000
Ekici S, Ayhan A, Kendi S et al. Determination of prognosis in patients with prostate cancer treated with radical prostatectomy: prognostic value of CD44v6 score. J Urol 167: 2037-2041, 2002
Ekici S, Cerwinka WH, Duncan R et al. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer. Int J Cancer 112: 121-129, 2004
Kaufmann M, Heider KH, Sinn HP et al. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619, 1995

ｍore...

, , , , , , ,

Return to Previous Page